Efficacy and Safety of Pioglitazone and Azilsartan in Treating Subjects With Type 2 Diabetes Mellitus
Status:
Completed
Trial end date:
2005-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy of pioglitazone, once daily (QD),
combined with azilsartan in the treatment of subjects with Type 2 Diabetes Mellitus.